Klotho Neurosciences, Inc. Quarterly Debt-to-equity in % from Q1 2023 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Klotho Neurosciences, Inc. quarterly Debt-to-equity history and growth rate from Q1 2023 to Q3 2024.
  • Klotho Neurosciences, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -221 %, a 64.3% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -221 +396 +64.3% Sep 30, 2024
Q2 2024 -277 +172 +38.3% Jun 30, 2024
Q1 2024 -193 +294 +60.4% Mar 31, 2024
Q4 2023 -877 Dec 31, 2023
Q3 2023 -617 Sep 30, 2023
Q2 2023 -450 Jun 30, 2023
Q1 2023 -486 Mar 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.